Colorectal Cancer
Copyright ©The Author(s) 2005.
World J Gastroenterol. Jul 14, 2005; 11(26): 3998-4002
Published online Jul 14, 2005. doi: 10.3748/wjg.v11.i26.3998
Table 1 Clinicopathologic features of double primary gastric and colorectal cancers
CaseSexAge (yr)OnsetGastric cancer
SiteColorectal cancer
DifferentiationTNStageDifferentiationTNStage
1Male49SynchronousDiffuse101TCModerate413/C
2Male35SynchronousIntestinal201ACMucinous323/C
3Male50MetachronousIntestinal201DCModerate313/C
4Male56SynchronousIntestinal101CModerate313/C
5Male68SynchronousIntestinal101SCMucinous302/B
6Male57SynchronousDiffuse101RModerate323/C
7Male54SynchronousIntestinal201SCModerate201/A
8Male61SynchronousIntestinal101ACModerate201/A
9Female76MetachronousIntestinal101TCModerate302/B
10Male65SynchronousIntestinal101ACModerate302/B
11Female65SynchronousDiffuse101ACMucinous313/C
12Male48MetachronousDiffuse???ACModerate323/C
13Male71SynchronousIntestinal101ACWell313/C
14Male65SynchronousDiffuse101SCModerate302/B
15Male59SynchronousIntestinal101ACMucinous302/B
16Male61MetachronousDiffuse201SCModerate313/C
Table 2 Microsatellite instability (MSI) and follow-up results of double primary gastric and colorectal cancers
CaseGastric cancer (GC)
Colorectal cancer (CRC)
Follow-up (mo)
bat26D5S346bat25D17S250D2S123MSIbat26D5S346bat25D17S250D2S123MSI
1HH21, alive, RGC
22, alive, RCRC
2HH88, alive, MGC, kidney
3HH58, alive, +AOV cancer
4HH10, alive, RCRC
5HI18, alive, NED
6LI38, alive, NED
7SS29, alive, NED
8SS18, alive, NED
9SS114, alive, NED
10SS85, alive, NED
11SS61, alive, NED
12SS82, alive, NED
13IS19, alive, NED
14SI17, alive, NED
15IS29, alive, NED
16IS67, alive, MCRC, lung
Table 3 Differences of double primary gastric and colorectal cancers according to microsatellite instability (MSI)
Both MSI-high (n = 4)Others (n = 12)P
Male : Female4:0010:02NS
Age (yr)47.5 ± 8.9 (35-56)62.5 ± 7.6 (48-76)NS
Gastric cancer
- intestinal : diffuse3:017:05NS
- size (cm)2.83.1NS
Colorectal cancer
- tubular : mucinous3 : 19 : 3NS
- size (cm)4.74.2NS
- node metastasis100%25%NS
- Dukes A : B : C0 : 0 : 42 : 5 : 5NS
Recurrence, metastasis,100%8.3%< 0.005
or other organ malignancy